GRCE Stock Analysis: Buy, Sell, or Hold?
GRCE - Grace Therapeutics, Inc. Common Stock
$2.08
0.00 (0.00%)
▲
5d:
-7.56%
30d:
-17.79%
90d:
-11.86%
HOLD
MODERATE Confidence
Analysis Updated: Aug 3, 2026 12:00 AM ET
Earnings: Aug 11, 2026
6d
Get Alerted When GRCE Hits Your Target Price
Join 10,000+ traders who never miss a move
You're in! Check your email to confirm and set your target price.
100% Free
No spam, ever
Unsubscribe anytime
Interactive Price Chart (1 Month)
Loading chart...
Loading historical data...
Bottom Line:
📊 HOLD: GRCE shows balanced signals. Fine to hold or accumulate slowly. Monitor for clearer direction.
📊 HOLD: GRCE shows balanced signals. Fine to hold or accumulate slowly. Monitor for clearer direction.
In-depth Analysis How we analyze
Valuation Analysis: GRCE is currently trading at $2.08, which is considered oversold relative to its 30-day fair value range of $2.27 to $2.47.
Technical Outlook: Technically, GRCE is in a strong downtrend. Immediate support is located at $1.85, while resistance sits at $2.48.
Market Sentiment: GRCE has a weak technical setup (25/100), with bearish trendlines and momentum suggesting caution for short-term entries. Wall Street analysts see significant upside, with an average price target of $6.04 (+190.3%). The stock is fairly positioned - fine to hold existing positions or accumulate slowly on dips, but not an urgent buy.
Technical Outlook: Technically, GRCE is in a strong downtrend. Immediate support is located at $1.85, while resistance sits at $2.48.
Market Sentiment: GRCE has a weak technical setup (25/100), with bearish trendlines and momentum suggesting caution for short-term entries. Wall Street analysts see significant upside, with an average price target of $6.04 (+190.3%). The stock is fairly positioned - fine to hold existing positions or accumulate slowly on dips, but not an urgent buy.
Quick Decision Summary
Current Position
OVERSOLD
Historical Trading Range
$2.27 -
$2.47
Company Quality Score
43/100
(HOLD)
Volume Confirmation
HIGH
Confidence Score
57.9%
All Signals
- BULLISH: Price oversold vs 30-day range
- BEARISH: Weak technical setup (25/100)
- BULLISH: High volume confirmation
- BULLISH: Trading 190.3% below Wall St target ($6.04)
- CAUTION: 5-day price weakness (-7.6%) - monitor closely
Trading Range Analysis
30-Day Trading Range
$2.27 -
$2.47
Current vs Trading Range
OVERSOLD
Support & Resistance Levels
Support Level
$1.85
Resistance Level
$2.48
Current Trend
Strong Downtrend
Technical data as of
Aug 3, 2026
Fundamental Context
Forward P/E (Next Year Est.)
-2.19
Wall Street Target
$6.04
(+190.3%)
Share & Embed Analysis
Last updated: August 04, 2026 9:50 AM ET
Data refreshes hourly during market hours. Next update: 10:50 AM
Data refreshes hourly during market hours. Next update: 10:50 AM
🔥 Top Stocks Breaking Out Now
| Ticker | Score | Recommendation | Change % |
|---|
Technical Signals Check
Is GRCE showing a specific setup today?
Insider Activity (6 Months)
0
Buys
0
Sells
0
Net
NEUTRAL
Top Rated Biotechnology Stocks
Top-rated stocks in Biotechnology by analyst ratings.
| Stock | Analyst Consensus | Analyst Target | Tradestie Score |
|---|---|---|---|
|
VRTX
Vertex Pharmaceuticals I… |
BUY
34 analysts |
$557 | 52 HOLD |
|
IONS
Ionis Pharmaceuticals Inc |
BUY
26 analysts |
$89 | 59 HOLD |
|
XENE
Xenon Pharmaceuticals Inc |
STRONG BUY
19 analysts |
$81 | 58 HOLD |
|
ACLX
Arcellx Inc |
STRONG BUY
18 analysts |
$113 | 57 HOLD |
|
VKTX
Viking Therapeutics Inc |
STRONG BUY
19 analysts |
$93 | 51 HOLD |